LORI MADDOX: Open Payments
NPI 1215900568 · PRINCE FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$722 in 31 payments from 11 companies in 2025. Trend: 2023 $16 · 2024 $839 · 2025 $722
Food & beverage: $722
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 7 | $210 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $119 |
| Grifols USA, LLC | 4 | $111 |
| AstraZeneca Pharmaceuticals LP | 6 | $100 |
| Amgen Inc. | 2 | $45 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| Genentech USA, Inc. | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| HARMONY BIOSCIENCES LLC | 1 | $18 |
| Electromed, Inc. | 1 | $16 |
Products named: DUPIXENT, Prolastin-C Liquid, OFEV, AIRSUPRA, FASENRA, Xolair, TRELEGY ELLIPTA, WAKIX.
Industry payments across MD — which companies pay providers there.
